معرفی
Marianne Stanford is an Adjunct Assistant Professor in the Department of Microbiology & Immunology at Dalhousie University's Faculty of Medicine. She is affiliated with the Vaccine Discovery group of the Canadian Centre for Vaccinology and the Beatrice Hunter Cancer Research Institute as an Associate Member. Her research focuses on cancer immunotherapy, vaccine development, and infectious diseases, with expertise in preclinical research and clinical immunology assessments.
- Education: BSc (Memorial University of Newfoundland), MSc (Memorial University of Newfoundland), PhD (Dalhousie University)
- Postdoctoral Training: Robarts Research Institute and Ottawa Hospital Research Institute (OHRI)
Her research interests include the development of novel cancer treatments using viral therapies, oncolytic virotherapy synergism with signaling inhibitors, and the creation of effective vaccines against infectious diseases like Respiratory Syncytial Virus (RSV). She also holds roles in science policy, including former Chair of the Canadian Association of Postdoctoral Scholars.
Dr. Stanford’s recent work emphasizes combination therapies involving immunomodulatory agents and vaccines, with a focus on enhancing T-cell activation and tumor microenvironment modulation. Key areas include the DPX-Survivac immunotherapy for ovarian cancer and lipid-based vaccine formulations.
Scientific Awards: None explicitly stated in the provided text.
Grants & Labs: Active in translational research through collaborations with institutions like IMV, Inc., and contributes to the Canadian Institute for Health Research (CIHR) as Assistant Scientific Director for the Institute of Infection and Immunity.
